0001209191-21-069154.txt : 20211210
0001209191-21-069154.hdr.sgml : 20211210
20211210212242
ACCESSION NUMBER: 0001209191-21-069154
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211208
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lettmann Jason
CENTRAL INDEX KEY: 0001688269
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 211486807
MAIL ADDRESS:
STREET 1: C/O RA PHARMACEUTICALS, INC.
STREET 2: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-08
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001688269
Lettmann Jason
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK
CA
94025
1
0
1
0
Common Stock
2021-12-08
4
S
0
35836
33.23
D
2232251
I
See footnote
Common Stock
2021-12-08
4
S
0
4883
33.23
D
304339
I
See footnote
Common Stock
2021-12-08
4
S
0
1531
33.80
D
2230720
I
See footnote
Common Stock
2021-12-08
4
S
0
208
33.80
D
304131
I
See footnote
Common Stock
2021-12-09
4
S
0
11452
31.08
D
2219268
I
See footnote
Common Stock
2021-12-09
4
S
0
1560
31.08
D
302571
I
See footnote
Common Stock
2021-12-09
4
S
0
42203
32.06
D
2177065
I
See footnote
Common Stock
2021-12-09
4
S
0
5751
32.06
D
296820
I
See footnote
Common Stock
2021-12-09
4
S
0
14028
32.73
D
2163037
I
See footnote
Common Stock
2021-12-09
4
S
0
1911
32.73
D
294909
I
See footnote
Common Stock
2021-12-10
4
S
0
7093
30.77
D
2155944
I
See footnote
Common Stock
2021-12-10
4
S
0
967
30.77
D
293942
I
See footnote
Common Stock
2021-12-10
4
S
0
15942
31.55
D
2140002
I
See footnote
Common Stock
2021-12-10
4
S
0
2172
31.55
D
291770
I
See footnote
Common Stock
2021-12-10
4
S
0
88
32.16
D
2139914
I
See footnote
Common Stock
2021-12-10
4
S
0
12
32.16
D
291758
I
See footnote
Common Stock
2023469
I
See footnote
Common Stock
120212
I
See footnote
Common Stock
107220
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.70 to $33.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held of record by shares held of record by Lightstone Ventures, LP (LV LP) for which LSV Associates, LLC (LSV Associates) is the General Partner. The reporting person shares voting and dispositive power with respect to the shares held of record by LV LP but disclaims beneficial ownership of such shares except to the extent of his individual pecuniary interest therein.
The shares are held of record by shares held of record by Lightstone Ventures (A), LP (LV(A) LP) for which LSV Associates is the General Partner. The reporting person shares voting and dispositive power with respect to the shares held of record by LV(A) LP but disclaims beneficial ownership of such shares except to the extent of his individual pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to $33.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.50 to $31.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.50 to $32.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.50 to $33.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.12 to $31.09 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $32.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held of record by Lightstone Ventures II, LP (LV II LP). As a managing director of LSV Associates II, LLC (LSV Associates II), the General Partner of LV II LP, the reporting person shares voting and dispositive power with respect to the shares held of record by LV II LP but disclaims beneficial ownership of such shares except to the extent of his individual pecuniary interest therein.
The shares are held of record by Lightstone Ventures II(A), LP (LV II(A) LP). As a managing director of LSV Associates II, the reporting person shares voting and dispositive power with respect to the shares held of record by LV II(A) LP but disclaims beneficial ownership of such shares except to the extent of his individual pecuniary interest therein.
/s/ Peter Garcia, by power of attorney
2021-12-10